oncology
Health Venture Partners led the round with participation from Breyer Capital, Kenan Turnacioglu and other funders.
The startup develops non-invasive blood tests that achieve early cancer detection and improve treatment selection.
The new office will support the firm’s plans for advanced injection, wearable devices and connected health technologies.
Bradford Power, founder of Reengineering Cancer Treatment and an author focused on process improvement, speaks from experience on why oncology treatment needs to become more personalized.
These include Wellthy Therapeutics, from India; OKKO Health, from the UK; and Carepay, from Kenya.
Oleena's algorithms serve patients personalized guidance on how best to mitigate symptoms, while also monitoring and generating insights for their care team.
Flow raises $1.5m, Healthy.io makes UTI test kits available in UK Boots pharmacies, and more news b…
Also: ONCOassist unveils partnership with MSD; new vice chair for the Academic Health Science Network in England is appointed; NHS England and NHS Improvement name deputy chief people officer.
Researchers carried out 17 interviews with doctors and nurses using a free oncology decision support app in Europe.
Although still far from being tested in humans, the technology could serve as a replacement to blood draws.